Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 12:42 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1273–1296 of 21,991 matching trials from the live ClinicalTrials.gov search.

Filters: Recruiting Clear all

Conditions: Healthy
Interventions: Dietary Supplement: Dietary supplement: Protein intake; Dietary Supplement
Lead sponsor: Arkansas Children's Hospital Research Institute; Other
Eligibility: 8 Years to 10 Years
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Pregnancy, Migraine, Headache, Postpartum, Depression, Anxiety
Interventions: external Trigeminal Nerve Stimulation; Device
Lead sponsor: Cefaly Technology; Industry
Eligibility: 18 Years to 44 Years · Female only
Enrollment: 550 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2030
U.S. locations: 1
States / cities: Darien, Connecticut

Conditions: Cheek Wrinkles, Menopausal Women
Interventions: Sculptra®; Device
Lead sponsor: Galderma R&D; Industry
Eligibility: 22 Years and older · Female only
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Miami, Florida • New York, New York

Conditions: Squamous Cell Carcinoma Head and Neck Cancer (HNSCC), Margin Assessment
Interventions: Indocyanine Green (ICG); Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Cigarette Smoker, Current Smoker, Lung Adenocarcinoma, Squamous Cell Lung Carcinoma, Stage IV Non-Small Cell Lung Cancer
Interventions: Best Practice, Biospecimen Collection, Laboratory Biomarker Analysis, Medical Chart Review, Quality-of-Life Assessment, Questionnaire Administration, Smoking Cessation Intervention; Other · Procedure · Behavioral
Lead sponsor: Ohio State University Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 3,584 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2028
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Cancer, Cancer Survivors, Gastrointestinal Cancers, Neuroendocrine Tumors, Multiple Myeloma, Neoplasms
Interventions: Implementation of social determinants of health screening and referral; Other
Lead sponsor: Barbara Ann Karmanos Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Type 1 Diabetes
Interventions: ACT1VATE, DSME/S; Behavioral
Lead sponsor: Scripps Whittier Diabetes Institute; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: San Diego, California

Conditions: COVID -19, COVID - 19, COVID 19, Influenza, Respiratory Virus, Respiratory Viruses, Respiratory Virus Infection, Respiratory Virus Infections
Interventions: Pfizer-BioNTech mRNA COVID-19 vaccine, Novavax recombinant protein vaccine; Drug
Lead sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine; Other
Eligibility: 18 Years to 79 Years
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Heart Failure, Chronic Heart Failure, Chronic Heart Disease
Interventions: Daily Voice Recording; Device
Lead sponsor: Noah Labs; Industry
Eligibility: 22 Years and older
Enrollment: 450 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Neuroendocrine Carcinoma Metastatic, Pancreatic Tumors
Interventions: [18F]FluorThanatrace; Drug
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: ARTHROPLASTY, REPLACEMENT
Interventions: Not listed
Lead sponsor: American Joint Replacement Registry; Other
Eligibility: Not listed
Enrollment: 500,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2029
U.S. locations: 1
States / cities: Rosemont, Illinois

Conditions: Peer Influence, Alcohol-Involved Sexual Violence Perpetration
Interventions: Sexual Imposition Task; Other
Lead sponsor: Georgia State University; Other
Eligibility: 21 Years and older · Male only
Enrollment: 320 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Soft Tissue Sarcoma
Interventions: hypofractionation; Radiation
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2032
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Diabetes Mellitus in Pregnancy, Type 2 Diabetes Mellitus (T2DM), Gestational Diabetes Mellitus, Class A2
Interventions: Insulin glargine, insulin NPH; Drug
Lead sponsor: Loyola University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Maywood, Illinois

Conditions: ADHD, Sleep Disturbance, Brain Fog
Interventions: Stasis Daytime and Nighttime, Placebo; Dietary Supplement
Lead sponsor: Outliers, Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Las Vegas, Nevada

Conditions: Major Depressive Disorder, Anhedonia
Interventions: Delta-beta tACS via the Neurocare Direct Current Stimulator Multi-Channel 4, Theta-gamma tACS via the Neurocare Direct Current Stimulator Multi-Channel 4, Sham tACS via the Neurocare Direct Current Stimulator Multi-Channel 4; Device
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 72 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Type 1 Diabetes
Interventions: Anti-thymocyte globulin (ATG), verapamil extended release capsule, Placebo; Drug
Lead sponsor: University of Florida; Other
Eligibility: 6 Years to 35 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 2
States / cities: Aurora, Colorado • Gainesville, Florida

Conditions: Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III, Carcinoma, Breast
Interventions: Neoadjuvant endocrine therapy; Drug
Lead sponsor: George Washington University; Other
Eligibility: 21 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Cognitive Behavioral Therapy
Interventions: cognitive behavioral therapy; Behavioral
Lead sponsor: University of Pittsburgh; Other
Eligibility: 21 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2028
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Fibromyalgia
Interventions: Energy Healing; Other
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years to 75 Years · Female only
Enrollment: 25 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Irvine, California

Conditions: Child Obesity, Cardiometabolic Health
Interventions: Brighter Bites; Other
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 6 Years to 9 Years
Enrollment: 720 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Malnutrition (Calorie)
Interventions: Not listed
Lead sponsor: Abbott Nutrition; Industry
Eligibility: 1 Year to 5 Years
Enrollment: 158 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Pulmonary Disease, Pulmonary Hypertension
Interventions: Not listed
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 270 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2013
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Fibromyalgia, Musculoskeletal Pain
Interventions: S-Cone Stimulating Chromatic Light, Equal-Energy White Light; Device
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Search by objective public record fields.

Protein Requirements for Active Children

External Trigeminal Nerve Stimulation for Migraine Treatment in Pregnancy

A Clinical Study to Assess Histological Changes From Treatment of Poly L-lactic Acid Biostimulator on Women at Various Menopausal Stages

Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors

Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer

Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors

ACT1VATE: Addressing Emotional Distress to Improve Outcomes Among Diverse Adults With Type 1 Diabetes

Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) Study

Voice-based Outcome Identification and Clinical Evaluation in Heart Failure

FTT PET/CT in Pancreatic Neuroendocrine Tumors

American Joint Replacement Registry

Peer Influences in Alcohol and Sexual Violence Among Marines Dyads

Pre-operative Hypofractionated Proton Therapy

RCT Glargine vs NPH for Treatment of DM in Pregnancy

A Study to Evaluate the Effects of a Supplement on the Side Effects Associated With Stimulant Medications

Causal Role of Delta-beta Coupling for Goal-directed Behavior in Anhedonic Depression

Precision Administration of Anti-thymocyte Globulin With or Without Verapamil

Predicting Response to Neoadjuvant Endocrine Therapy (Neo-PREDICT)

Fear of Recurrence and Stopping Immunotherapy

The Effects of Energy Healing in Fibromyalgia

Evaluating the Impact of a School-based Fruit and Vegetable Co-op on Cardiometabolic Child and Parents Health in a Persistent Poverty Area

Stunting and Targeting Reduction of Impaired Growth in Kids Effectively

Natural History Study of Biomarkers in Pulmonary Arterial Hypertension

Light Bulb Stimuli to Reduce Chronic Pain